Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
J Neurosci ; 21(18): 7110-6, 2001 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-11549721

RESUMEN

Osmotic regulation of supraoptic nucleus (SON) neuron activity depends in part on activation of neuronal glycine receptors (GlyRs), most probably by taurine released from adjacent astrocytes. In the neurohypophysis in which the axons of SON neurons terminate, taurine is also concentrated in and osmo-dependently released by pituicytes, the specialized glial cells ensheathing nerve terminals. We now show that taurine release from isolated neurohypophyses is enhanced by hypo-osmotic and decreased by hyper-osmotic stimulation. The high osmosensitivity is shown by the significant increase on only 3.3% reduction in osmolarity. Inhibition of taurine release by 5-nitro-2-(3-phenylpropylamino)benzoic acid, niflumic acid, and 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid suggests the involvement of volume-sensitive anion channels. On purified neurohypophysial nerve endings, activation of strychnine-sensitive GlyRs by taurine or glycine primarily inhibits the high K(+)-induced rise in [Ca(2+)](i) and subsequent release of vasopressin. Expression of GlyRs in vasopressin and oxytocin terminals is confirmed by immunohistochemistry. Their implication in the osmoregulation of neurohormone secretion was assessed on isolated whole neurohypophyses. A 6.6% hypo-osmotic stimulus reduces by half the depolarization-evoked vasopressin secretion, an inhibition totally prevented by strychnine. Most importantly, depletion of taurine by a taurine transport inhibitor also abolishes the osmo-dependent inhibition of vasopressin release. Therefore, in the neurohypophysis, an osmoregulatory system involving pituicytes, taurine, and GlyRs is operating to control Ca(2+) influx in and neurohormone release from nerve terminals. This elucidates the functional role of glial taurine in the neurohypophysis, reveals the expression of GlyRs on axon terminals, and further defines the role of glial cells in the regulation of neuroendocrine function.


Asunto(s)
Neuroglía/metabolismo , Neurohipófisis/metabolismo , Terminales Presinápticos/metabolismo , Receptores de Glicina/metabolismo , Taurina/metabolismo , Vasopresinas/metabolismo , Ácido 4,4'-Diisotiocianostilbeno-2,2'-Disulfónico/farmacología , Animales , Calcio/metabolismo , Canales de Cloruro/metabolismo , Glicina/farmacología , Glicinérgicos/farmacología , Inmunohistoquímica , Técnicas In Vitro , Masculino , Ácido Niflúmico/farmacología , Nitrobenzoatos/farmacología , Concentración Osmolar , Oxitocina/metabolismo , Neurohipófisis/citología , Neurohipófisis/efectos de los fármacos , Terminales Presinápticos/efectos de los fármacos , Ratas , Ratas Wistar , Receptores de Glicina/efectos de los fármacos , Núcleo Supraóptico/citología , Núcleo Supraóptico/fisiología , Taurina/farmacología
3.
Br J Pharmacol ; 130(8): 1976-82, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-10952690

RESUMEN

To characterize the volume-sensitive, osmolyte permeable anion channels responsible for the osmodependent release of taurine from supraoptic nucleus (SON) astrocytes, we investigated the pharmacological properties of the [(3)H]-taurine efflux from acutely isolated SON. Taurine release induced by hypotonic stimulus (250 mosmol l(-1)) was not antagonized by the taurine transporter blocker guanidinoethyl sulphonate, confirming the lack of implication of the transporter. The osmodependent release of taurine was blocked by a variety of Cl(-) channel inhibitors with the order of potency: NPPB>niflumic acid>DPC>DIDS>ATP. On the other hand, release of taurine was only weakly affected by other compounds (dideoxyforskolin, 4-bromophenacyl bromide, mibefradil) known to block volume-activated anion channels in other cell preparations, and was completely insensitive to tamoxifen, a broad inhibitor of these channels. Although the molecular identity of volume-sensitive anion channels is not firmly established, a few genes have been postulated as potential candidates to encode such channels. We checked the expression in the SON of three of them, ClC(3), phospholemman and VDAC(1), and found that the transcripts of these genes are found in SON neurons, but not in astrocytes. Similar observation was previously reported for ClC(2). In conclusion, the osmodependent taurine permeable channels of SON astrocytes display a particular pharmacological profile, suggesting the expression of a particular type or subtype of volume-sensitive anion channel, which is likely to be formed by yet unidentified proteins.


Asunto(s)
Colforsina/análogos & derivados , Canales Iónicos/efectos de los fármacos , Neuroglía/efectos de los fármacos , Núcleo Supraóptico/efectos de los fármacos , Taurina/metabolismo , Ácido 4,4'-Diisotiocianostilbeno-2,2'-Disulfónico/farmacología , Acetofenonas/farmacología , Adenosina Trifosfato/farmacología , Animales , Bloqueadores de los Canales de Calcio/farmacología , Canales de Cloruro/efectos de los fármacos , Canales de Cloruro/genética , Colforsina/farmacología , Difusión , Relación Dosis-Respuesta a Droga , Expresión Génica , Hibridación in Situ , Canales Iónicos/genética , Masculino , Mibefradil/farmacología , Neuroglía/citología , Neuroglía/metabolismo , Ácido Niflúmico/farmacología , Nitrobenzoatos/farmacología , Presión Osmótica , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Núcleo Supraóptico/citología , Núcleo Supraóptico/metabolismo , Tamoxifeno/farmacología , ortoaminobenzoatos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA